Novo CEO pressed by Senate to chop costs of weight problems, diabetes medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into consideration new talks with insurers regarding the record price ranges of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. https://codymdtje.yomoblog.com/36985767/the-smart-trick-of-healthcare-news-that-nobody-is-discussing